In 2026, transformation is no longer a strategic advantage. It is a baseline expectation. Across manufacturing, FMCG, and pharmaceutical sectors, organisations are investing heavily in digitalisation, automation, sustainability, and operational restructuring. The ambition is clear. The investment is significant. Yet the results are often underwhelming. Despite better tools, smarter technologies, and more data than ever before, many transformation programmes still fail to deli

In complex organisations, strategy is rarely the problem. Most companies already know what they want to achieve: Major CAPEX investment programmes Manufacturing and production expansion Digital and automation transformation Infrastructure and utilities upgrades Operational restructuring and site optimisation The challenge is not ambition. The challenge is execution in technically complex environments where engineering, operations, and business priorities must align under pres